[Intravenous infusion of molsidomine in infarct therapy].
Krankenanstalten Düren, Akademisches Lehrkankenhaus, RWTH Aachen.
B
B
Zentgraf
A
A
Costard-Jäckle
M
M
Fuchs
K
K
Funke
G
G
Kreymann
J
J
Lessmann
F G
FG
Nowak
H R
HR
Milstrey
E G
EG
Schmidt
H
H
Simon
D000368:Aged; D000369:Aged, 80 and over; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005080:Exercise Test / Q000187:drug effects; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D008981:Molsidomine / Q000008:administration & dosage* / Q000009:adverse effects; D009203:Myocardial Infarction / Q000188:drug therapy*
D008981:Molsidomine
Die intravenöse Infusion von Molsidomin in der Infarkttherapie.